NanoMedex Pharmaceuticals Inc. has patent rights to an innovative and proprietary formulation technology based on the utilization of nanotechnology for fatty-based drug solubization. The technology utilizes components that encapsulate the active pharmaceutical ingredient of drugs into spheres so small they allow the drug to become randomly dispersed in water. NanoMedex is now building a pipeline of drug products based on already FDA-approved active pharmaceutical ingredients that are reformulated with the NanoMedex formulation strategy for intravenous administration to patients.